Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice

Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy

(2011) S. Danese et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cannabis use amongst patients with inflammatory bowel disease

(2011) Simon Lal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55

(2011) Niklas Schuelert et al.   NEUROSCIENCE LETTERS

Plasma Cannabinoid Pharmacokinetics following Controlled Oral  9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration

(2010) E. L. Karschner et al.   CLINICAL CHEMISTRY

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

(2010) Rudolf Schicho et al.   INFLAMMATORY BOWEL DISEASES

New pathophysiological insights and modern treatment of IBD

(2010) Matthias A. Engel et al.   JOURNAL OF GASTROENTEROLOGY

Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies

(2010) Rudolf Schicho et al.   Expert Review of Clinical Pharmacology

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

(2009) Martin A. Storr et al.   INFLAMMATORY BOWEL DISEASES

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Cannabinoids in intestinal inflammation and cancer

(2009) Angelo A. Izzo et al.   PHARMACOLOGICAL RESEARCH

Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue

(2009) Lucia Marquéz et al.   PLoS One

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

(2008) Martin A. Storr et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY